ESMO Preceptorship on Head & Neck Cancer 2018: Zurich
![ESMO Preceptorship on Head and Neck Cancer Zurich 2018 banner](/var/esmo/storage/images/media/images/conferences/2018/preceptorships-2018/esmo-preceptorship-on-head-and-neck-cancer-zurich-2018-banner/2374246-1-eng-GB/ESMO-Preceptorship-on-Head-and-Neck-Cancer-Zurich-2018-banner.jpg)
- Start date
- 22 May 2018
- End date
- 23 May 2018
- Location
- Zurich, Switzerland
Learning objectives
- To understand epidemiology, aetiology and molecular biology of squamous cell carcinoma of the head and neck
- To understand multidisciplinary management and treatment of head and neck cancer
- To learn about advances in the treatment and novel targets in head and neck cancer
- To learn about salivary gland cancer
Accreditation
The programme of this event has been accredited with 10 ESMO-MORA category 1 points. certification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Viktor Grünwald, Germany
- Jean-Pascal Machiels, Belgium